West Pharmaceutical Services Inc (WST) - Total Assets
Based on the latest financial reports, West Pharmaceutical Services Inc (WST) holds total assets worth $4.11 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check West Pharmaceutical Services Inc (WST) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
West Pharmaceutical Services Inc - Total Assets Trend (1985–2025)
This chart illustrates how West Pharmaceutical Services Inc's total assets have evolved over time, based on quarterly financial data. Explore WST strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
West Pharmaceutical Services Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
West Pharmaceutical Services Inc's total assets of $4.11 Billion consist of 46.3% current assets and 53.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $791.30 Million | 18.5% |
| Accounts Receivable | $574.40 Million | 13.5% |
| Inventory | $443.90 Million | 10.4% |
| Property, Plant & Equipment | $1.84 Billion | 43.2% |
| Intangible Assets | $7.70 Million | 0.2% |
| Goodwill | $109.90 Million | 2.6% |
Asset Composition Trend (1985–2025)
This chart illustrates how West Pharmaceutical Services Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see WST company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: West Pharmaceutical Services Inc's current assets represent 46.3% of total assets in 2025, an increase from 31.6% in 1985.
- Cash Position: Cash and equivalents constituted 18.5% of total assets in 2025, up from 4.8% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is property, plant & equipment at 43.2% of total assets.
West Pharmaceutical Services Inc Competitors by Total Assets
Key competitors of West Pharmaceutical Services Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tecan Group AG
SW:TECN
|
Switzerland | CHF1.94 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Formosa Optical Technology Co Ltd
TWO:5312
|
Taiwan | NT$9.15 Billion |
|
ZEN Graphene Solutions Ltd
V:ZEN
|
Canada | CA$16.87 Million |
|
GETS Global Bhd
KLSE:5079
|
Malaysia | RM400.10 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
West Pharmaceutical Services Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.71 | 2.77 | 3.13 |
| Quick Ratio | 2.04 | 2.03 | 2.39 |
| Cash Ratio | 0.00 | 0.77 | 1.22 |
| Working Capital | $1.15 Billion | $930.80 Million | $1.00 Billion |
West Pharmaceutical Services Inc - Advanced Valuation Insights
This section examines the relationship between West Pharmaceutical Services Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.91 |
| Latest Market Cap to Assets Ratio | 5.43 |
| Asset Growth Rate (YoY) | 17.2% |
| Total Assets | $4.27 Billion |
| Market Capitalization | $23.17 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values West Pharmaceutical Services Inc's assets at a significant premium (5.43x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: West Pharmaceutical Services Inc's assets grew by 17.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for West Pharmaceutical Services Inc (1985–2025)
The table below shows the annual total assets of West Pharmaceutical Services Inc from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $4.27 Billion | +17.20% |
| 2024-12-31 | $3.64 Billion | -4.86% |
| 2023-12-31 | $3.83 Billion | +5.88% |
| 2022-12-31 | $3.62 Billion | +9.14% |
| 2021-12-31 | $3.31 Billion | +18.61% |
| 2020-12-31 | $2.79 Billion | +19.32% |
| 2019-12-31 | $2.34 Billion | +47.04% |
| 2018-12-31 | $1.59 Billion | -14.52% |
| 2017-12-31 | $1.86 Billion | +8.51% |
| 2016-12-31 | $1.72 Billion | +1.27% |
| 2015-12-31 | $1.70 Billion | +1.45% |
| 2014-12-31 | $1.67 Billion | -0.04% |
| 2013-12-31 | $1.67 Billion | +6.88% |
| 2012-12-31 | $1.56 Billion | +11.79% |
| 2011-12-31 | $1.40 Billion | +8.10% |
| 2010-12-31 | $1.29 Billion | +1.83% |
| 2009-12-31 | $1.27 Billion | +8.75% |
| 2008-12-31 | $1.17 Billion | -1.43% |
| 2007-12-31 | $1.19 Billion | +29.12% |
| 2006-12-31 | $918.20 Million | +11.49% |
| 2005-12-31 | $823.60 Million | +25.03% |
| 2004-12-31 | $658.70 Million | +5.63% |
| 2003-12-31 | $623.60 Million | +16.17% |
| 2002-12-31 | $536.80 Million | +4.99% |
| 2001-12-31 | $511.30 Million | -8.27% |
| 2000-12-31 | $557.40 Million | +1.01% |
| 1999-12-31 | $551.80 Million | +9.14% |
| 1998-12-31 | $505.60 Million | +5.80% |
| 1997-12-31 | $477.90 Million | +0.10% |
| 1996-12-31 | $477.40 Million | -0.56% |
| 1995-12-31 | $480.10 Million | +20.81% |
| 1994-12-31 | $397.40 Million | +29.28% |
| 1993-12-31 | $307.40 Million | +0.99% |
| 1992-12-31 | $304.40 Million | -2.81% |
| 1991-12-31 | $313.20 Million | -8.82% |
| 1990-12-31 | $343.50 Million | +9.74% |
| 1989-12-31 | $313.00 Million | +4.72% |
| 1988-12-31 | $298.90 Million | +6.71% |
| 1987-12-31 | $280.10 Million | +17.99% |
| 1986-12-31 | $237.40 Million | +32.63% |
| 1985-12-31 | $179.00 Million | -- |
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; sy… Read more